两项研究证明氟替卡松安特酰胺鼻腔喷雾治疗并不影响这些重要的生长指标和激素功能。
Both studies demonstrated that treatment with FFNS did not affect these important indicators of growth and hormonal function.
在两项与安慰剂相对照的研究中均发现氟替卡松安特酰胺鼻腔喷雾能有效减轻鼻部症状且通常耐受良好。
In both studies FFNS was found to be effective in reducing nasal symptoms, compared to placebo, and was generally well-tolerated.
这些鼓舞人心的资料表明：氟替卡松安特酰胺鼻腔喷雾是临床医生和父母治疗变态反应性鼻炎患儿症状的一种新的选择。
These encouraging data suggest that FFNS could offer clinicians and parents a viable new treatment option for children with nasal allergies.
对558名2 ~11岁常年性变态反应性鼻炎患儿进行另一项研究，以安慰剂组为对照，比较氟替卡松安特酰胺鼻腔喷雾110mcg和55mcg长期治疗的效果。
Another study compared the effects of long-term treatment with FFNS at 110 MCG and 55 MCG, versus placebo, of year-round allergies in 558 children ages 2 through 11.
对558名2 ~11岁常年性变态反应性鼻炎患儿进行另一项研究，以安慰剂组为对照，比较氟替卡松安特酰胺鼻腔喷雾110mcg和55mcg长期治疗的效果。
Another study compared the effects of long-term treatment with FFNS at 110 MCG and 55 MCG, versus placebo, of year-round allergies in 558 children ages 2 through 11.
应用推荐